Wird geladen...

Checkpoint inhibitor therapy for metastatic triple-negative breast cancer

Immunotherapy has become a mainstay of cancer treatment in many malignancies, though its application in breast cancer remains limited. Of the breast cancer subtypes, triple-negative breast cancers (TNBCs) are characterized by immune activation and infiltration and more commonly express biomarkers as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Metastasis Rev
Hauptverfasser: Heeke, Arielle L., Tan, Antoinette R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer US 2021
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8184866/
https://ncbi.nlm.nih.gov/pubmed/34101053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-021-09972-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!